Current through Register Vol. 61, No. 4, April 1, 2022
processor may only process and transfer medical cannabinoid products,
concentrates or extracts if the processor has received an endorsement from the
Authority for that type of processing activity. Endorsements types are:
(a) Cannabinoid edible processor;
(b) Cannabinoid topical processor;
(c) Cannabinoid concentrate
(d) Cannabinoid extract
tincture, capsule, suppository, or transdermal patch processor.
(2) An applicant must request an
endorsement upon submission of an initial application but may also request an
endorsement at any time following registration.
(3) In order to apply for an endorsement an
applicant or processing site registrant must submit a form prescribed by the
Authority that includes a description of the type of products to be processed,
a description of equipment to be used, and any solvents, gases, chemicals or
other compounds proposed to be used to create extracts or
(4) Only one
application and registration fee is required regardless of how many
endorsements an applicant or registrant requests or at what time the request is
(5) A processing site
registrant may hold multiple endorsements.
(6) For the purposes of endorsements any
cannabinoid product that is intended to be consumed orally is considered a
(7) If a
processor is no longer going to process the product for which the processor is
endorsed the processor must notify the Authority in writing and provide the
date on which the processing of that product will cease.
Or. Admin. R.
9-2016, f. 2-26-16, cert. ef.
170-2018, minor correction filed 04/30/2018, effective
219-2018, minor correction filed 05/17/2018, effective
Statutory/Other Authority: ORS 475B.840 & 475B.849
Statutes/Other Implemented: ORS 475B.840 & 475B.849